Bawang, Aya Azkiyyah B.
HRN: 23-76-38 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/12/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/12/2024
08/19/2024
IV
300mg
IV
PCAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes